Cerevast Therapeutics has recently closed the first part of its Series “C” financing. Read the Notice of Exempt Offering of Securities on file with the U.S. Securities and Exchange commission.
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. The company’s headquarters are located in Redmond, Washington.